Near future
Contact us
  • Home
  • Tech
  • Health
  • Environment
  • Architecture
  • energia
  • Transportation
  • Spazio
  • AI
  • concepts
  • Gadgets
  • Italy Next
  • H+
July 2 2022

Coronavirus / Russia-Ukraine

Near future

News to understand, anticipate, improve the future.

No Result
View All Result

News to understand, anticipate, improve the future.

Read in:  Chinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

Asthma, a mix of drugs reduces attacks by 24%. Researchers: It's a paradigm shift

The new drug mix works asthma in the hips, improving lung function, reducing attacks and mitigating flare-ups.

Gianluca Ricciodi Gianluca Riccio
in Technology
Share34Pin9Tweet22SendShare6ShareShare4
Asthma
May 28, 2022
⚪ Reads in 3 minutes
A A

Asthma affects between 100 and 150 million people worldwide. Today a clinical study shows that using a new combination of two drugs significantly reduced their chances of suffering an acute attack.

Participants in the study, published in the New England Journal of Medicinereceived a mix of two drugs via inhaler. One, albuterol, relaxes smooth muscle and is used to relieve acute asthma. The other, budesonide, is a corticosteroid. Together, the two drugs reduced unexpected episodes of wheezing, wheezing and coughing - things you can't mess with, sometimes leading to hospital, or in more rare cases to death.

Asthma

A paradigm shift

“This cure is a paradigm shift in asthma treatment. We look forward to this first of its kind combination treatment becoming part of standard therapy ", says author Reynold Panettieri Jr. , professor of medicine at Rutgers Robert Wood Johnson Medical School.

Maybe you are also interested

2050, 1 billion climate refugees. How to manage (or avoid) the great exodus

From solar to thermoelectric, the new 'reincarnation' of exhausted panels

The first CRISPR therapy arrives in 2023: it will hit thalassemia and rare blood diseases

Ecological and labor transition: the 'fossil' fires, the 'green' assumes

The Phase 3 Mandala clinical trial, involving more than 3.000 asthma patients at 295 sites in the United States, Europe and South America, evaluated the safety and efficacy of a mix of salbuterol and budesonide as a therapy for people with mild to severe asthma.

It is an evolution of several standard treatments, which involve a "rescue" medicine such as salbuterol via the inhaler, and subsequently doses of oral steroids (less frequently, due to the strong side effects). This mix brings together the benefits while mitigating the inconveniences.

The Asthma Treatment Study

Patients were divided into three groups: two received the mix of the two drugs in different dosages, one third received a placebo. Results? Patients who received the drug improved their lung function and experienced fewer attacks.

Scientists have found that salbuterol with the highest dose of budesonide reduces the risk of an asthma attack 27% in the short term e 24% per year. This combination has also reduced 33% use of corticosteroids.

In other words, this new inhaler delivers what you need, when you need it and in the right dose, while also protecting you from flare-ups.

A good breath of air, it must be said.

Previous post

NASA changes its mind about UFOs, or rather UAPs: it will join the investigation after the last hearing in the US Congress

Next Post

A 'millirobot' climbs through the intestines to administer drugs

COLLABORATE

To submit articles, disclose the results of a research or scientific discoveries write to the editorial staff

    archive

    Have a look here:

    Biological age
    Medicine

    From a study an 8-week plan that reduces the biological age by 3 years

    A one of a kind study produces a real plan to reduce (by 3 years, for now) the age ...

    Read More
    Smart ID Carde, the super smart badge

    Goodbye badge: Smart ID, the universal e-paper card

    Ice

    Scientists create flexible (and super cold) ice

    coronavirus shield

    DARPA is studying a coronavirus "shield"

    These 'electronic algae' generate energy from the wave motion

    These 'electronic algae' generate energy from the wave motion

    The daily tomorrow

    Futuroprossimo.it provides news on the future of technology, science and innovation: if there is something that is about to arrive, here it has already arrived. FuturoProssimo is part of the network ForwardTo, studies and skills for future scenarios.

    Subscribe to our newsletter

    Environment
    Architecture
    Artificial intelligence
    Gadgets
    concepts
    Design

    Staff
    Archives
    Advertising
    Privacy Policy

    Medicine
    Spazio
    Robotica
    Work
    Transportation
    energia

    To contact the FuturoProssimo editorial team, write to [email protected]

    Chinese Version
    Édition Française
    Deutsche Ausgabe
    Japanese version
    English Edition
    Edição Portuguesa
    Русское издание
    Spanish edition

    This work is distributed under license Creative Commons Attribution 4.0 International.
    © 2021 Futuroprossimo

    No Result
    View All Result
    • Home
    • Tech
    • Health
    • Environment
    • Architecture
    • energia
    • Transportation
    • Spazio
    • AI
    • concepts
    • Gadgets
    • Italy Next
    • H+